Expression and function of efflux drug transporters in the intestine

被引:268
作者
Takano, M [1 ]
Yumoto, R [1 ]
Murakami, T [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Program Pharmaceut Sci, Dept Pharmaceut & Therapeut,Minami Ku, Hiroshima 7348551, Japan
关键词
ABC transporter; P-glycoprotein; multidrug resistance-associated protein 2; breast cancer resistance protein; oral bioavailability; transporter-mediated drug interaction;
D O I
10.1016/j.pharmthera.2005.06.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of drug transporters expressed in the body control the fate of drugs by affecting absorption, distribution, and elimination processes. In the small intestine, transporters mediate the influx and efflux of endogenous or exogenous substances. In clinical pharmacotherapy, ATP-dependent efflux transporters (ATP-binding cassette [ABC] transporters) expressed on the apical membrane of the intestinal epithelial cells determine oral bioavailability, intestinal efflux clearance, and the site of drug-drug interaction of certain drugs. The expression and functional activity of efflux transporters exhibit marked interindividual variation and are relatively easily modulated by factors such as therapeutic drugs and daily foods and beverages. In this article, we will summarize the recent findings regarding the intestinal efflux transporters, especially P-glycoprotein (P-gp or human multidrug resistance gene [MDR] 1), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP). (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:137 / 161
页数:25
相关论文
共 244 条
[1]   Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen [J].
Adachi, Y ;
Suzuki, H ;
Schinkel, AH ;
Sugiyama, Y .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :923-928
[2]   Quantitative evaluation of the function of small intestinal P-glycoprotein:: Comparative studies between in situ and in vitro [J].
Adachi, Y ;
Suzuki, H ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2003, 20 (08) :1163-1169
[3]   Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease [J].
Adibi, SA .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2003, 285 (05) :G779-G788
[4]  
Allen JD, 2003, CANCER RES, V63, P1339
[5]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[6]  
Allikmets R, 1998, CANCER RES, V58, P5337
[7]   P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[8]   The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours [J].
Bart, J ;
Hollema, H ;
Groen, HJM ;
de Vries, EGE ;
Hendrikse, NH ;
Sleijfer, DT ;
Wegman, TD ;
Vaalburg, W ;
van der Graaf, WTA .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (14) :2064-2070
[9]  
Batrakova EV, 2001, J PHARMACOL EXP THER, V299, P483
[10]   Serum cholestasis markers as predictors of early outcome after liver transplantation [J].
Ben-Ari, Z ;
Weiss-Schmilovitz, H ;
Sulkes, J ;
Brown, M ;
Bar-Nathan, N ;
Shaharabani, E ;
Yussim, A ;
Shapira, Z ;
Tur-Kaspa, R ;
Mor, E .
CLINICAL TRANSPLANTATION, 2004, 18 (02) :130-136